# A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846

> **NCT07404735** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 32 (estimated)

## Conditions studied

- Benign Prostate Hypertrophy(BPH)

## Interventions

- **DRUG:** CKD-846
- **DRUG:** D091

## Key facts

- **NCT ID:** NCT07404735
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-23
- **Primary completion:** 2026-05-27
- **Final completion:** 2026-06-02
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2026-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07404735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07404735, "A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT07404735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*